In July 2021, following consultation with the Therapeutic Goods Administration (TGA), Philips Australia and New Zealand announced an Urgent Product Defect Correction in Australia for specific Philips Continuous Positive Airway Pressure (CPAP), BiLevel Positive Airway Pressure (BiLevel PAP) devices, and Mechanical Ventilators.
Globally, we have remediated 99% of actionable* sleep therapy device registrations to date.
As the remediation of the ventilator devices continues, please visit the Ventilation page [insert hyperlink: https://www.philips.com.au/healthcare/e/sleep/communications/src-update/news/ventilation-news-and-updates] for news and updates.
In Australia, we continue to support patients with an affected device. As a first step, if your device is affected, please start the registration process here.
Our goods and services come with guarantees that cannot be excluded under the Australian and New Zealand Consumer Law. Your rights under the Australian and New Zealand Consumer Law are in addition to any remedy the local Philips entity may provide you.
*Actionable registrations are those that contain the necessary information needed to complete the remediation and are not awaiting further information.
Further information in relation to the global recall and devices has been made available by the legal manufacturer, Philips RS North America LLC (Philips Respironics), a company based in the USA.
The following updates in relation to device testing have been released by Philips Respironics on this webpage:
Please note that the Philips Respironics website also contains information specific to the CPAP, BiPAP and mechanical ventilator device recall in the USA, which may be different to and not relevant for Australia and New Zealand. This information has not been separately verified by Philips Electronics Australia Ltd.
Further information in relation to the global recall has been made available by Koninklijke Philips N.V. (Royal Philips), a company based in the Netherlands.
The following updates in relation to the global recall and recent media articles have been released by Royal Philips on the below webpages:
This information has not been separately verified by Philips Electronics Australia Ltd.
All Affected Devices Manufactured Before 26 April 2021, All Device Serial Numbers
(excluding Reworked CPAP and BiPAP Devices* with a label on the base showing Rev 15 or a higher number)
*Reworked CPAP and BiPAP Devices are new devices which have been reworked with new silicone sound abatement foam and a new internal air pathway and blower. While these Reworked CPAP and BiPAP Devices have a manufacturing date prior to 26 April 2021, they have never been used and are not affected by the correction. All Reworked CPAP and BiPAP Devices have a label on the base showing REV (short for revision) 15 or a higher number (refer example label above).
(Emergency Use Authorization)
Also known as DreamStation BiPAP autoSV
Also known as DreamStation BiPAP AVAPS, DreamStation BiPAP S/T
Also known as System One BiPAP autoSV, System One BiPAP autoSV Advanced
Also known as System One BiPAP AVAPS (C-Series), System One BiPAP S/T (C-Series)
In-Lab Titration Device
Also known as BiPAP A40 Ventilator (A-Series)
(not marketed in US)
Also known as BiPAP A30 Ventilator (A-Series)
(not marketed in US)
If your device is affected...
Products that are not affected may have different sound abatement foam materials, as new materials and technologies are available over time. Also, sound abatement foam in unaffected devices may be placed in a different location due to device design.
You are about to visit a Philips global content page
Continue